ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

HROW Harrow Inc

10.58
0.05 (0.47%)
최종 업데이트: 22:45:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Harrow Inc HROW 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.05 0.47% 10.58 22:45:09
개장가 저가 고가 종가 전일 종가
10.57 10.52 10.66 10.53
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00BWHarrow Will Release First Quarter 2024 Financial Results..
02/04/202421:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
20/03/202420:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
20/03/202406:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
19/03/202420:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
06/03/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202421:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
22/02/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202409:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:15EDGAR2Form 8-K - Current report
16/02/202406:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
10/02/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:30EDGAR2Form 8-K - Current report
30/01/202405:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/01/202421:00BWHarrow Announces New Appointments to its Board of Directors
11/01/202421:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
10/01/202400:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/01/202422:00EDGAR2Form 8-K - Current report
03/01/202421:15BWMelt Pharmaceuticals Provides Corporate Update
03/01/202421:00BWHarrow Partners with Leading Healthcare Market Access..
29/11/202321:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
20/11/202321:00BWHarrow to Present at Two Investor Conferences in November
17/11/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202309:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:34EDGAR2Form 8-K - Current report
14/11/202306:01BWHarrow Announces Third Quarter 2023 Financial Results
04/11/202305:52EDGAR2Form 8-K - Current report
30/10/202321:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
24/10/202320:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
30/09/202305:01EDGAR2Form 8-K - Current report
29/09/202321:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
26/09/202321:00BWMelt Pharmaceuticals Announces Exclusive Development and..
21/09/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:05EDGAR2Form 8-K - Current report
10/08/202305:01BWHarrow Announces Second Quarter 2023 Financial Results
31/07/202320:00BWHarrow Launches VIGAMOX® in the U.S.
26/07/202322:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
22/07/202305:02EDGAR2Form 8-K - Current report
21/07/202308:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202306:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/07/202320:00BWHarrow Prices $60 Million Public Offering of Common Stock
19/07/202311:55BWHarrow erwirbt US-amerikanische und kanadische..
19/07/202306:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/07/202306:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
19/07/202305:59EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock